A clinical study of pyridoxine treatment for pervasive developmental disorders with hypersensitivity to sound

Machiko Kamiyama, Shinichi Kuriyama, Mikako Watanabe

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

In our earlier study we conducted a randomized, placebo-controlled, triple blind trial, and showed that pyridoxine treatment of pervasive developmental disorders with expressive verbal disorders and hypersensitivity to sound as significantly effective in improving VIQ scores. This study analyzed the long-term changes of the subjects. We confirmed that their VIQ scores improved over time. An analysis of the reports of their daily life provided by their parents and teachers showed that the children's hypersensitivity to sound was also improved. They became able to adjust to their daily life at home and school without any panic. Our results indicate there are PDD subgroups whose expressive language capabilities and hypersensitivity to sound can be improved by pyridoxine treatment.

Original languageEnglish
Pages (from-to)277-282
Number of pages6
JournalNo To Hattatsu
Volume38
Issue number4
Publication statusPublished - 2006

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Fingerprint Dive into the research topics of 'A clinical study of pyridoxine treatment for pervasive developmental disorders with hypersensitivity to sound'. Together they form a unique fingerprint.

Cite this